Phase 2–4 trials
MASH / liver disease · Live ClinicalTrials.gov data
Resmetirom (Rezdiffra) clinical trial pipeline
ClinicalTrials.gov lists 12 phase 2–4 trials for resmetirom (Rezdiffra), 4 of them actively recruiting. The next phase 3 primary completion among them is expected Dec 2026. Refreshed daily. Add up to four competitors to compare pipelines side by side.
Phase 3 trials
Actively recruiting
Next phase 3 primary completion
Participants across trials
Lead sponsor by trial count
resmetirom
Upcoming readouts
8 ahead · resmetirom
Key resmetirom trials
Top 12 of the 12 registered phase 2–4 trials, ordered by phase and status. Trial names open the full ComplyRx trial page; NCT ids link to ClinicalTrials.gov.
Track resmetirom with ComplyRx
Get an alert when a trial changes status, moves its completion date, or a new trial registers in scope. Checked nightly against ClinicalTrials.gov.
Related drug pipelines
FAQ
- How many clinical trials are running for resmetirom?
- ClinicalTrials.gov currently lists 12 phase 2–4 resmetirom trials: 5 phase 2, 4 phase 3, and 3 phase 4. 4 are actively recruiting.
- Are there clinical trials for Rezdiffra?
- Rezdiffra is the brand name for resmetirom, so resmetirom trials on ClinicalTrials.gov cover it. ClinicalTrials.gov currently lists 12 phase 2–4 resmetirom trials: 5 phase 2, 4 phase 3, and 3 phase 4. 4 are actively recruiting.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare resmetirom against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
